Paul Bennett
About Paul Bennett
Paul Bennett is a Senior Scientist at Bristol Myers Squibb in Cambridge, Massachusetts, with over a decade of experience in biomedical research, specializing in oncology and cell therapy.
Title at Bristol Myers Squibb
Paul Bennett currently holds the position of Sr. Scientist at Bristol Myers Squibb. Located in Cambridge, Massachusetts, he has been contributing to oncology drug discovery projects since June 2021. His role involves leading research initiatives aimed at developing new cancer therapies.
Previous Role at Novartis
Prior to his current role, Paul Bennett served as a Sr. Scientist II at Novartis Institutes for BioMedical Research (NIBR) from 2016 to 2021. During his five-year tenure, he specialized in CAR-T Cell Therapy, focusing on innovative treatments for cancer patients. His work at NIBR significantly contributed to his expertise in the field of cell therapy.
Early Career at Brigham and Women's Hospital
Paul Bennett began his professional career at Brigham and Women's Hospital, where he worked as a Laboratory Manager from 2010 to 2016. In this role, he oversaw laboratory operations, managing activities and ensuring compliance with regulatory standards. This position marked his entry into the biomedical research industry and laid the foundation for his subsequent roles in scientific research.
Education in Biology
Paul Bennett has a strong educational background in biology. He earned a Bachelor of Arts (BA) in Biology from Clark University and subsequently completed a Master's degree in Biology at Harvard Extension School. His academic credentials have provided a solid foundation for his extensive career in biomedical research.
Expertise in CAR-T Cell Therapy
Paul Bennett possesses substantial expertise in CAR-T Cell Therapy, developed during his tenure at Novartis Institutes for BioMedical Research. This specialized knowledge enables him to contribute effectively to research in the field of oncology and advanced cell therapy treatments.